Novocure Ltd expected to post a loss of 50 cents a share - Earnings Preview

NovoCure

25/07/2023 19:34

* Novocure Ltd  NVCR.OQ   NVCR.O  is expected to show a fall
in
quarterly revenue when it reports  results on July 27. 
    * The Saint Helier Jersey-based   company is expected to
report  a
11.8% decrease in revenue to $124.26 million from $140.87
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Novocure Ltd is for
a
loss of 50 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Novocure
Ltd is
$73.5​, above​ its last closing price of $38.33. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.31       -0.32      -0.50     Missed  -54.5
 Dec. 31 2023  -0.31       -0.30      -0.36     Missed  -18
 Sep. 30 2022  -0.26       -0.26      -0.25     Beat    4.4​
 Jun. 30 2022  -0.16       -0.14      -0.23     Missed  -58.6
 ​​Mar.        -0.18       -0.18      -0.04     Beat    77.8
 31 2022                                                
 Dec. 31 2021  -0.09       -0.10      -0.25     Missed  -146.5
                                                        ​
 Sep. 30 2021  -0.07       -0.07      -0.13     Missed  -76.3
 Jun. 30 2021  0.00        0.01       -0.14     Missed  -1,674
                                                        .8
 This summary was machine generated July 25 at 18:34 GMT.  All
figures in US dollars  unless otherwise stated